Besponsa
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0008-0100 -
Package NDC
0008-0100-01 -
Application number
BLA761040 -
SPL ID
427d10d2-c29d-4b71-a5fe-c97736d59aa6 -
SPL set ID
cc7014b1-c775-411d-b374-8113248b4077 -
UNII
P93RUU11P7 -
RxCUI
1942954 -
RxCUI
1942959
What the source publishes
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Active ingredients
- inotuzumab ozogamicin
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Besponsa",
"splId": "427d10d2-c29d-4b71-a5fe-c97736d59aa6",
"labels": [
{
"setId": "cc7014b1-c775-411d-b374-8113248b4077",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc7014b1-c775-411d-b374-8113248b4077",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=cc7014b1-c775-411d-b374-8113248b4077"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "0008-0100-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20170818"
}
],
"productId": "0008-0100_427d10d2-c29d-4b71-a5fe-c97736d59aa6",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "0008-0100",
"deaSchedule": null,
"genericName": "inotuzumab ozogamicin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INOTUZUMAB OZOGAMICIN",
"strength": ".25 mg/mL"
}
],
"applicationNumber": "BLA761040",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20170818",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000193617",
"N0000193616",
"N0000008576",
"N0000009176",
"M0028142"
],
"unii": [
"P93RUU11P7"
],
"rxcui": [
"1942954",
"1942959"
],
"spl_set_id": [
"cc7014b1-c775-411d-b374-8113248b4077"
],
"pharm_class_cs": [
"Immunoconjugates [CS]"
],
"pharm_class_pe": [
"Decreased DNA Integrity [PE]",
"Increased Cellular Death [PE]"
],
"pharm_class_epc": [
"CD22-directed Immunoconjugate [EPC]"
],
"pharm_class_moa": [
"CD22-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0008-0100_427d10d2-c29d-4b71-a5fe-c97736d59aa6"